Q3-19 10-Q

Company

KalVista Pharmaceuticals, Inc.

Filed

March 14, 2019

Period of Report

January 31, 2019

Accession Number

0001564590-19-007827

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →